{"id":6379,"date":"2026-04-29T11:12:25","date_gmt":"2026-04-29T11:12:25","guid":{"rendered":"https:\/\/voxzogopatient-pprd-001.azurewebsites.net\/en-us\/?page_id=6379"},"modified":"2026-06-18T10:18:26","modified_gmt":"2026-06-18T10:18:26","slug":"inhibited-bone-growth","status":"publish","type":"page","link":"https:\/\/www.voxzogo.com\/en-us\/inhibited-bone-growth\/","title":{"rendered":"Inhibited Bone Growth"},"content":{"rendered":"
Bones grow for a limited time. In achondroplasia<\/span>, the growth of bones that develop from cartilage<\/span> (called endochondral bones) is inhibited. This can impact physical development, including reduced and disproportionate growth.<\/strong><\/p>\n See how physical development is tracked for children with achondroplasia.<\/p>\n Download Growth Charts<\/a><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n *Based on stature-for-age data (birth to 18 years old) from CLARITY, an achondroplasia natural history study comprising measurements from 549 males and 502 females with achondroplasia.<\/small><\/p>\n<\/figcaption>\n <\/figure>\n <\/div>\n <\/div>\n<\/div>\n\n Endochondral bone growth<\/span> occurs in areas of the bones called growth plates<\/span> and requires a balance of two cell signals—FGFR3 (which slows growth) and CNP<\/span> (which promotes growth). In achondroplasia<\/span>, the FGFR3<\/span> signals are overactive, causing an imbalance that inhibits bone growth.<\/strong><\/p>\n <\/div>\n\n This graphic is an illustration of the cell signaling imbalance in achondroplasia and is not to scale. Treatment to help promote bone growth from birth.<\/p>\n \n \n Growth charts specific to children with achondroplasia are important when tracking physical development.<\/p>\n \n Download<\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n Your local BioMarin representative can help you find answers.<\/p>\n \n Endochondral bone growth is inhibited in achondroplasia—that’s over 90% of the body’s bones.<\/h2>\n <\/div>\n <\/div>\n \n
<\/div>\n <\/figure>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\nThe most rapid growth occurs in the first 2 years of life<\/h2>\n
\nBy 2 years old, children with achondroplasia<\/span> reach more than half of their adult height*<\/strong><\/p>\n <\/div>\n\n
\t\t\t<\/div>\n\t\t\t
\t\t\t<\/div>\n <\/div>\n Bone growth is inhibited by imbalanced cell signals<\/h2>\n
<\/div>\n <\/figure>\n <\/div>\n <\/div>\n<\/div>\n\n
\n<\/small>CNP<\/span><\/strong>, C-type natriuretic peptide; FGFR3<\/span><\/strong>, fibroblast growth factor receptor 3.<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\nSee how VOXZOGO works<\/h3>\n \n
Learn More <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
<\/div>\n\n Tracking your child’s growth<\/h3>\n
Looking for more information about VOXZOGO?<\/h2>\n <\/div>\n